Unlock Premium for Just $9.99/Month – Special Launch Offer, Limited Time Only
Get Premium
AHCO AdaptHealth Corp
- Stocks
- Healthcare
- NASDAQ: AHCO
Price (delayed)
$8.96
Market cap
$1.21B
P/E Ratio
15.45
Dividend/share
N/A
EPS
$0.58
Enterprise value
$3.26B
AdaptHealth is a leading provider of home healthcare equipment, medical supplies to the home and related services in the United States. AdaptHealth provides a full suite of medical products and
Highlights
The debt is down by 10% year-on-year
AHCO's equity is up by 7% year-on-year
The net income has soared by 112% YoY but it has contracted by 6% from the previous quarter
The EPS has surged by 111% year-on-year but it has declined by 6% since the previous quarter
AHCO's quick ratio is down by 20% year-on-year and by 10% since the previous quarter
Key stats
What are the main financial stats of AHCO
Market
Valuations
Earnings
Shares outstanding
134.95M
Market cap
$1.21B
Enterprise value
$3.26B
Price to earnings (P/E)
15.45
Price to book (P/B)
0.77
Price to sales (P/S)
0.37
EV/EBIT
13.39
EV/EBITDA
5
EV/Sales
1
Revenue
$3.25B
Gross profit
$684.73M
Operating income
$236.37M
Net income
$85.35M
EBIT
$243.42M
EBITDA
$652.05M
Free cash flow
$279.9M
Per share
Balance sheet
Liquidity
EPS
$0.58
EPS diluted
$0.57
Free cash flow per share
$2.08
Book value per share
$11.62
Revenue per share
$24.08
TBVPS
$12.62
Total assets
$4.44B
Total liabilities
$2.86B
Debt
$2.1B
Equity
$1.57B
Working capital
$168.44M
Debt to equity
1.34
Current ratio
1.29
Quick ratio
0.82
Net debt/EBITDA
3.14
Margins
Efficiency
Dividend
EBITDA margin
20.1%
Gross margin
21.1%
Net margin
2.6%
Operating margin
7.3%
Return on assets
1.9%
Return on equity
5.6%
Return on invested capital
7.6%
Return on capital employed
6.3%
Return on sales
7.5%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
AHCO stock price
How has the AdaptHealth stock price performed over time
Intraday
-0.67%
1 week
-0.22%
1 month
1.24%
1 year
-19.42%
YTD
-5.88%
QTD
-17.34%
Financial performance
How have AdaptHealth's revenue and profit performed over time
Revenue
$3.25B
Gross profit
$684.73M
Operating income
$236.37M
Net income
$85.35M
Gross margin
21.1%
Net margin
2.6%
AHCO's operating income has surged by 141% year-on-year but it is down by 10% since the previous quarter
AdaptHealth's operating margin has surged by 141% YoY but it has decreased by 10% QoQ
The net margin has soared by 112% year-on-year but it is down by 7% since the previous quarter
The net income has soared by 112% YoY but it has contracted by 6% from the previous quarter
Price vs fundamentals
How does AHCO's price correlate with its fundamentals
Growth
What is AdaptHealth's growth rate over time
Valuation
What is AdaptHealth stock price valuation
P/E
15.45
P/B
0.77
P/S
0.37
EV/EBIT
13.39
EV/EBITDA
5
EV/Sales
1
The EPS has surged by 111% year-on-year but it has declined by 6% since the previous quarter
AHCO's P/B is 91% lower than its 5-year quarterly average of 8.7 and 13% lower than its last 4 quarters average of 0.9
AHCO's equity is up by 7% year-on-year
The stock's price to sales (P/S) is 63% less than its 5-year quarterly average of 1.0 and 8% less than its last 4 quarters average of 0.4
Efficiency
How efficient is AdaptHealth business performance
The company's return on invested capital has surged by 142% YoY but it fell by 3.8% QoQ
The return on sales has surged by 140% year-on-year but it has declined by 5% since the previous quarter
The company's return on equity has surged by 114% YoY but it fell by 7% QoQ
The ROA has soared by 113% YoY but it has decreased by 5% QoQ
Dividends
What is AHCO's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for AHCO.
Financial health
How did AdaptHealth financials performed over time
The total assets is 55% more than the total liabilities
AHCO's quick ratio is down by 20% year-on-year and by 10% since the previous quarter
AdaptHealth's total liabilities has decreased by 6% YoY
The debt is 34% greater than the equity
AHCO's debt to equity is down by 16% year-on-year
The debt is down by 10% year-on-year
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.